U.S. markets closed
  • S&P Futures

    4,362.00
    +18.50 (+0.43%)
     
  • Dow Futures

    34,305.00
    +130.00 (+0.38%)
     
  • Nasdaq Futures

    14,836.50
    +71.75 (+0.49%)
     
  • Russell 2000 Futures

    2,236.40
    +10.40 (+0.47%)
     
  • Crude Oil

    74.71
    -0.58 (-0.77%)
     
  • Gold

    1,734.50
    -3.00 (-0.17%)
     
  • Silver

    22.49
    +0.02 (+0.08%)
     
  • EUR/USD

    1.1689
    0.0000 (-0.00%)
     
  • 10-Yr Bond

    1.5340
    +0.0500 (+3.37%)
     
  • Vix

    23.25
    +4.49 (+23.93%)
     
  • GBP/USD

    1.3542
    +0.0001 (+0.01%)
     
  • USD/JPY

    111.5690
    +0.0890 (+0.08%)
     
  • BTC-USD

    41,092.94
    -1,189.90 (-2.81%)
     
  • CMC Crypto 200

    1,013.70
    -43.44 (-4.11%)
     
  • FTSE 100

    7,028.10
    -35.30 (-0.50%)
     
  • Nikkei 225

    29,613.15
    -570.81 (-1.89%)
     

With the Alexion Acquisition Set to Close This Quarter, Is AstraZeneca a Buy?

·3 min read
With the Alexion Acquisition Set to Close This Quarter, Is AstraZeneca a Buy?
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

With UK approval, the $39 billion deal for rare disorders biotech company Alexion Pharmaceuticals is set to close on July 21.